Skip to content
DataLookout
Menu

NCT06554392

Identification of Serum Level of Glutathione Peroxidase 4

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Sep 1, 2026 to Sep 1, 2027 Show 5 more changesShow less
    • Recruitment opened
    • Eligibility criteria expanded, about 6 words
    • Study completion pushed from Jul 1, 2027 to Jul 1, 2028
    • Study sites: 0 to 1
    • Publications: details revised at 5 of 5 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Analysis of the serum level of glutathione peroxidase 4 (GPX4) in ankylosing spondylitis and axial psoriatic arthritis patients.
Timeframe: baseline

Secondary (1)

The association of glutathione peroxidase 4 (GPX4) with disease activity and severity in ankylosing spondylitis and axial psoriatic arthritis patients.

Arms and interventions

Ankylosing Spondylitis patients

Identification of Glutathione Peroxidase 4 in blood.

Axial Psoriatic Arthritis Patients

Identification of Glutathione Peroxidase 4 in blood.

healthy controls

Identification of Glutathione Peroxidase 4 in blood.

Diagnostic tests: Blood sample

Sites

1 site in 1 country

  • Faculty of Medicine- Assiut UniversityAsyut, Egypt